Big Pharma's Latest Move: Acquisition Unlocks $15 Million Market Opportunity in the U.S.!
Big Pharma's Latest Move: Acquisition Unlocks $15 Million Market Opportunity in the U.S.!
Pharma Company Expands Injectable Portfolio with New Launch Targeting U.S. Hospital Market
Pharma Company Expands Injectable Portfolio with New Launch Targeting U.S. Hospital Market
Pharma Extends Crucial Support to Indices Amidst Broader Market Downturn, This Pharma Major Scaled Up 2.12 Per Cent
The company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing Facility in Somerset, New Jersey
The Company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing Facility in Somerset, New Jersey
Pharma Stock to Watch! FIIs & DIIs Bet Big as This Drugmaker Launches a New Eye Treatment in the US!
FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market!
FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market!
This Small-Cap Pharma Stock is Up 6 per cent! Lands Major Orders from 3 Countries!
A leading player in personal protection and healthcare products expands its international footprint
A leading player in personal protection and healthcare products expands its international footprint
Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company
FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance
FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance
Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar
A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price.
A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price.
Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches!
With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence
With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence
This Multibagger Pharma Stock Secures Strategic Foothold in Europe — Is It Set for Massive Growth?
Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue Streams
Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue Streams
Sensex Dips While Mid & Small-Caps Shine Bright!
Nifty 50 Slips, But Broader Markets Lead the Charge; Consumer Durables and Pharma Sectors Outperform
Nifty 50 Slips, But Broader Markets Lead the Charge; Consumer Durables and Pharma Sectors Outperform
Midday Market Mix: Sensex & Nifty Slip, But Midcaps & Smallcaps Shine Bright!
Pharma, Consumer Durables Lead Gains as Bajaj Finance & Adani Ports Drag; Market Breadth Stays Positive
Pharma, Consumer Durables Lead Gains as Bajaj Finance & Adani Ports Drag; Market Breadth Stays Positive
Exciting developments in the pharma industry that could skyrocket your portfolio; have a look
Previously revolutionising the IT industry, these technological advancements are currently enhancing efficiency, productivity and cost control in the pharmaceutical industry
Previously revolutionising the IT industry, these technological advancements are currently enhancing efficiency, productivity and cost control in the pharmaceutical industry
Don’t miss the action in this pharmaceutical stock: The Cup and handle pattern breakout is seen with huge volumes!
Notably, the RSI has entered a super bullish territory, indicating a significant shift in momentum.
The Nifty Pharmaceutical index has surged by an impressive 30 per cent on a year-to-date basis in 2023, significantly outperforming the Nifty 50 index. Against the backdrop of India experiencing a single-day spike of 628 new COVID-19 cases